Tudor Moldoveanu
Concepts (231)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
bcl-2 Homologous Antagonist-Killer Protein | 9 | 2022 | 17 | 4.050 |
Why?
| Apoptosis | 21 | 2024 | 1112 | 3.850 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 13 | 2022 | 129 | 3.750 |
Why?
| Mitochondria | 8 | 2024 | 404 | 2.320 |
Why?
| Mitochondrial Membranes | 8 | 2021 | 21 | 1.950 |
Why?
| Calpain | 14 | 2010 | 25 | 1.850 |
Why?
| bcl-2-Associated X Protein | 7 | 2023 | 56 | 1.560 |
Why?
| Protein Kinases | 4 | 2019 | 71 | 1.520 |
Why?
| BH3 Interacting Domain Death Agonist Protein | 8 | 2023 | 14 | 1.370 |
Why?
| Inositol Phosphates | 2 | 2019 | 13 | 0.830 |
Why?
| Membrane Proteins | 2 | 2022 | 353 | 0.750 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2019 | 19 | 0.690 |
Why?
| Protein Conformation | 11 | 2020 | 168 | 0.690 |
Why?
| Animals | 29 | 2024 | 13246 | 0.660 |
Why?
| Crystallography, X-Ray | 10 | 2022 | 148 | 0.660 |
Why?
| Cell Membrane Permeability | 2 | 2018 | 28 | 0.650 |
Why?
| Necrosis | 1 | 2018 | 178 | 0.610 |
Why?
| Binding Sites | 10 | 2020 | 375 | 0.570 |
Why?
| Calcium | 6 | 2008 | 400 | 0.520 |
Why?
| Permeability | 6 | 2019 | 68 | 0.490 |
Why?
| Protein Structure, Tertiary | 11 | 2016 | 253 | 0.470 |
Why?
| Amino Acid Sequence | 16 | 2020 | 586 | 0.470 |
Why?
| Models, Molecular | 12 | 2020 | 341 | 0.470 |
Why?
| Catalytic Domain | 3 | 2008 | 57 | 0.400 |
Why?
| Molecular Sequence Data | 13 | 2010 | 793 | 0.390 |
Why?
| Phosphorylation | 5 | 2019 | 534 | 0.380 |
Why?
| Humans | 27 | 2022 | 50208 | 0.380 |
Why?
| Liposomes | 3 | 2022 | 53 | 0.380 |
Why?
| Protein Multimerization | 5 | 2016 | 48 | 0.370 |
Why?
| Ligands | 3 | 2022 | 205 | 0.360 |
Why?
| Protein Binding | 7 | 2020 | 665 | 0.350 |
Why?
| Protein Structure, Secondary | 7 | 2018 | 72 | 0.340 |
Why?
| Enzyme Activation | 4 | 2019 | 275 | 0.340 |
Why?
| Signal Transduction | 8 | 2020 | 1622 | 0.340 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2018 | 245 | 0.330 |
Why?
| Calcium-Binding Proteins | 1 | 2008 | 54 | 0.320 |
Why?
| Mice | 12 | 2024 | 5759 | 0.300 |
Why?
| Glycoproteins | 2 | 2007 | 117 | 0.300 |
Why?
| Leucine | 2 | 2004 | 117 | 0.290 |
Why?
| Zinc Compounds | 1 | 2006 | 1 | 0.290 |
Why?
| Leupeptins | 3 | 2006 | 7 | 0.280 |
Why?
| Chlorides | 1 | 2006 | 50 | 0.280 |
Why?
| Cell Death | 3 | 2022 | 182 | 0.280 |
Why?
| Kinetics | 4 | 2020 | 631 | 0.270 |
Why?
| Protein Processing, Post-Translational | 2 | 2020 | 171 | 0.230 |
Why?
| Cytochromes c | 3 | 2020 | 29 | 0.230 |
Why?
| bcl-X Protein | 5 | 2017 | 50 | 0.230 |
Why?
| Rats | 9 | 2008 | 3299 | 0.220 |
Why?
| Fatty Acids | 1 | 2024 | 145 | 0.220 |
Why?
| Dimerization | 3 | 2020 | 50 | 0.220 |
Why?
| HT29 Cells | 2 | 2019 | 12 | 0.210 |
Why?
| Proto-Oncogene Proteins | 4 | 2017 | 149 | 0.210 |
Why?
| Cell Survival | 3 | 2019 | 602 | 0.200 |
Why?
| Calcium Signaling | 1 | 2002 | 56 | 0.200 |
Why?
| Lipids | 1 | 2022 | 148 | 0.200 |
Why?
| Sequence Alignment | 6 | 2011 | 122 | 0.180 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 828 | 0.180 |
Why?
| Cytochromes | 1 | 2020 | 3 | 0.180 |
Why?
| Molecular Conformation | 2 | 2019 | 67 | 0.180 |
Why?
| Cytosol | 1 | 2020 | 82 | 0.180 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2018 | 5 | 0.170 |
Why?
| Sf9 Cells | 1 | 2019 | 1 | 0.170 |
Why?
| Spodoptera | 1 | 2019 | 5 | 0.170 |
Why?
| Mutation | 4 | 2018 | 1294 | 0.170 |
Why?
| Peptide Fragments | 6 | 2017 | 213 | 0.160 |
Why?
| Alzheimer Disease | 1 | 2022 | 317 | 0.160 |
Why?
| Cell Line | 2 | 2019 | 1021 | 0.160 |
Why?
| Structural Homology, Protein | 1 | 2018 | 9 | 0.160 |
Why?
| Ion Channel Gating | 1 | 2018 | 39 | 0.160 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 35 | 0.160 |
Why?
| Carrier Proteins | 1 | 2020 | 306 | 0.160 |
Why?
| Protein Stability | 1 | 2018 | 44 | 0.150 |
Why?
| Histones | 1 | 2020 | 313 | 0.150 |
Why?
| Mutagenesis | 1 | 2018 | 60 | 0.150 |
Why?
| Androgen Receptor Antagonists | 1 | 2017 | 1 | 0.150 |
Why?
| Glycine | 1 | 2018 | 75 | 0.150 |
Why?
| Receptors, Androgen | 1 | 2017 | 46 | 0.150 |
Why?
| Fibroblasts | 2 | 2016 | 351 | 0.140 |
Why?
| Tumor Suppressor Proteins | 1 | 2017 | 128 | 0.140 |
Why?
| Colonic Neoplasms | 1 | 2018 | 159 | 0.140 |
Why?
| Recombinant Fusion Proteins | 2 | 2011 | 186 | 0.140 |
Why?
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 1 | 0.140 |
Why?
| Repressor Proteins | 1 | 2017 | 153 | 0.140 |
Why?
| Transcription, Genetic | 1 | 2017 | 369 | 0.130 |
Why?
| Cysteine Proteinase Inhibitors | 2 | 2007 | 22 | 0.130 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2016 | 15 | 0.130 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2015 | 20 | 0.130 |
Why?
| Apoptosis Regulatory Proteins | 3 | 2011 | 86 | 0.130 |
Why?
| Recombinant Proteins | 3 | 2006 | 487 | 0.120 |
Why?
| Models, Biological | 2 | 2015 | 723 | 0.120 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2015 | 203 | 0.120 |
Why?
| Coenzyme A | 1 | 2013 | 8 | 0.110 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 13 | 0.110 |
Why?
| Xenopus laevis | 1 | 2013 | 38 | 0.110 |
Why?
| Hydrolysis | 2 | 2003 | 62 | 0.110 |
Why?
| Oocytes | 1 | 2013 | 74 | 0.110 |
Why?
| Mutant Proteins | 1 | 2013 | 37 | 0.110 |
Why?
| Mice, Inbred C57BL | 1 | 2018 | 1819 | 0.110 |
Why?
| Mitochondria, Liver | 1 | 2011 | 70 | 0.100 |
Why?
| Substrate Specificity | 2 | 2008 | 193 | 0.090 |
Why?
| Sequence Homology, Amino Acid | 3 | 2010 | 144 | 0.090 |
Why?
| Receptors, Interleukin-4 | 1 | 2010 | 4 | 0.090 |
Why?
| Alternative Splicing | 2 | 2017 | 56 | 0.090 |
Why?
| Interleukin-4 | 1 | 2010 | 43 | 0.090 |
Why?
| Selection, Genetic | 1 | 2010 | 23 | 0.090 |
Why?
| Evolution, Molecular | 1 | 2010 | 99 | 0.090 |
Why?
| Structure-Activity Relationship | 2 | 2008 | 401 | 0.080 |
Why?
| EF Hand Motifs | 1 | 2008 | 1 | 0.080 |
Why?
| Protease Inhibitors | 2 | 2006 | 58 | 0.080 |
Why?
| Biocatalysis | 1 | 2008 | 14 | 0.080 |
Why?
| Mice, Knockout | 3 | 2017 | 846 | 0.080 |
Why?
| Cathepsins | 2 | 2007 | 7 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 3 | 2003 | 99 | 0.080 |
Why?
| Phenotype | 2 | 2017 | 733 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 3 | 0.070 |
Why?
| Ubiquitin | 1 | 2007 | 45 | 0.070 |
Why?
| Neoplasms | 1 | 2017 | 1249 | 0.070 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2007 | 10 | 0.070 |
Why?
| KB Cells | 1 | 2006 | 5 | 0.070 |
Why?
| Epoxy Compounds | 1 | 2007 | 45 | 0.070 |
Why?
| Gene Expression Regulation | 1 | 2011 | 979 | 0.070 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 103 | 0.070 |
Why?
| Micelles | 1 | 2006 | 4 | 0.070 |
Why?
| Peptide Library | 1 | 2005 | 16 | 0.070 |
Why?
| Phospholipids | 1 | 2006 | 57 | 0.070 |
Why?
| Isoenzymes | 2 | 2006 | 169 | 0.060 |
Why?
| Papain | 1 | 2004 | 3 | 0.060 |
Why?
| Cathepsin K | 1 | 2004 | 7 | 0.060 |
Why?
| Crystallization | 1 | 2004 | 32 | 0.060 |
Why?
| Magnesium | 2 | 2004 | 36 | 0.060 |
Why?
| Protein Isoforms | 2 | 2002 | 119 | 0.060 |
Why?
| Peptides | 1 | 2005 | 223 | 0.060 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 863 | 0.060 |
Why?
| Coenzyme A Ligases | 1 | 2024 | 4 | 0.060 |
Why?
| Transposases | 1 | 2004 | 10 | 0.060 |
Why?
| Protein Precursors | 1 | 2004 | 43 | 0.060 |
Why?
| Transfection | 2 | 2017 | 355 | 0.060 |
Why?
| Calorimetry, Differential Scanning | 1 | 2003 | 8 | 0.060 |
Why?
| Calcium Chloride | 1 | 2003 | 2 | 0.060 |
Why?
| HEK293 Cells | 2 | 2017 | 224 | 0.060 |
Why?
| Protein Folding | 1 | 2003 | 49 | 0.060 |
Why?
| Restriction Mapping | 1 | 2003 | 32 | 0.060 |
Why?
| Cell Proliferation | 2 | 2017 | 1013 | 0.060 |
Why?
| Molecular Mimicry | 2 | 2017 | 38 | 0.050 |
Why?
| Tryptophan | 1 | 2003 | 99 | 0.050 |
Why?
| Proteins | 1 | 2006 | 345 | 0.050 |
Why?
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2022 | 1 | 0.050 |
Why?
| Oxidation-Reduction | 1 | 2024 | 320 | 0.050 |
Why?
| Temperature | 1 | 2003 | 168 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 2 | 2003 | 1378 | 0.050 |
Why?
| RNA Splicing | 1 | 2022 | 37 | 0.050 |
Why?
| Endoplasmic Reticulum | 2 | 2016 | 118 | 0.050 |
Why?
| Cell Membrane | 2 | 2016 | 251 | 0.050 |
Why?
| Molecular Structure | 2 | 2017 | 296 | 0.050 |
Why?
| Muscular Dystrophies | 1 | 2001 | 15 | 0.050 |
Why?
| Chymotrypsin | 1 | 2001 | 3 | 0.050 |
Why?
| Trypsin | 1 | 2001 | 12 | 0.050 |
Why?
| Molecular Weight | 1 | 2001 | 85 | 0.050 |
Why?
| Mammals | 2 | 2011 | 58 | 0.050 |
Why?
| Catalysis | 1 | 2001 | 88 | 0.050 |
Why?
| Proteome | 1 | 2022 | 173 | 0.050 |
Why?
| Sequence Homology | 1 | 2020 | 20 | 0.050 |
Why?
| Amino Acid Motifs | 1 | 2020 | 57 | 0.050 |
Why?
| Molecular Dynamics Simulation | 1 | 2020 | 33 | 0.050 |
Why?
| Jurkat Cells | 1 | 2018 | 29 | 0.040 |
Why?
| Herpesvirus 1, Human | 1 | 2018 | 15 | 0.040 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 21 | 0.040 |
Why?
| Muscle Proteins | 1 | 2001 | 312 | 0.040 |
Why?
| Anilides | 1 | 2017 | 19 | 0.040 |
Why?
| NIH 3T3 Cells | 1 | 2017 | 52 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 96 | 0.040 |
Why?
| Mice, SCID | 1 | 2017 | 176 | 0.040 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 212 | 0.040 |
Why?
| RNA Interference | 1 | 2017 | 179 | 0.040 |
Why?
| Mice, Nude | 1 | 2017 | 254 | 0.040 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 180 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2018 | 388 | 0.030 |
Why?
| Genotype | 1 | 2017 | 534 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2016 | 66 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2016 | 117 | 0.030 |
Why?
| Indoles | 1 | 2017 | 278 | 0.030 |
Why?
| Caspase 2 | 1 | 2013 | 1 | 0.030 |
Why?
| Transcriptional Activation | 1 | 2013 | 121 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2017 | 1416 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2013 | 136 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2017 | 1037 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2011 | 27 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 2922 | 0.020 |
Why?
| HeLa Cells | 1 | 2011 | 260 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2010 | 26 | 0.020 |
Why?
| Likelihood Functions | 1 | 2010 | 54 | 0.020 |
Why?
| Calorimetry | 1 | 2010 | 6 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 192 | 0.020 |
Why?
| Multigene Family | 1 | 2010 | 56 | 0.020 |
Why?
| Protein Interaction Mapping | 1 | 2010 | 40 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 305 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 198 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2010 | 238 | 0.020 |
Why?
| Phylogeny | 1 | 2010 | 234 | 0.020 |
Why?
| Genetic Variation | 1 | 2010 | 213 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1186 | 0.020 |
Why?
| Autophagy | 1 | 2010 | 169 | 0.020 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2007 | 51 | 0.020 |
Why?
| Solutions | 1 | 2006 | 24 | 0.020 |
Why?
| Hydrogen Bonding | 1 | 2006 | 31 | 0.020 |
Why?
| Conserved Sequence | 1 | 2006 | 56 | 0.020 |
Why?
| Electron Spin Resonance Spectroscopy | 1 | 2006 | 10 | 0.020 |
Why?
| Cysteine | 1 | 2006 | 50 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 30 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 176 | 0.020 |
Why?
| Water | 1 | 2006 | 75 | 0.020 |
Why?
| Consensus Sequence | 1 | 2005 | 24 | 0.020 |
Why?
| Chromatography, Gel | 1 | 2005 | 38 | 0.020 |
Why?
| Biotinylation | 1 | 2005 | 26 | 0.020 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 16 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 63 | 0.020 |
Why?
| Acetylation | 1 | 2005 | 97 | 0.020 |
Why?
| Computer Simulation | 1 | 2006 | 280 | 0.020 |
Why?
| Nitrilotriacetic Acid | 1 | 2004 | 1 | 0.010 |
Why?
| Edetic Acid | 1 | 2004 | 14 | 0.010 |
Why?
| Nickel | 1 | 2004 | 11 | 0.010 |
Why?
| Chelating Agents | 1 | 2004 | 27 | 0.010 |
Why?
| Sequence Deletion | 1 | 2004 | 67 | 0.010 |
Why?
| Salts | 1 | 2000 | 8 | 0.010 |
Why?
| Serine | 1 | 2000 | 37 | 0.010 |
Why?
| Point Mutation | 1 | 2000 | 65 | 0.010 |
Why?
| Cysteine Endopeptidases | 1 | 2000 | 67 | 0.010 |
Why?
| Lysine | 1 | 2000 | 89 | 0.010 |
Why?
| Glutamic Acid | 1 | 2000 | 108 | 0.010 |
Why?
| Male | 1 | 2017 | 25399 | 0.010 |
Why?
| Female | 1 | 2017 | 26635 | 0.010 |
Why?
|
|
Moldoveanu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|